MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 497.40
0.00 (0.00%)
Jun 12, 2026, 5:29 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 7.47 billion as of June 12, 2026. Its market cap has increased by 11.46% in one year.
Market Cap
7.47B
Enterprise Value
7.56B
Revenue
2.18B
Ranking
n/a
PE Ratio
33.16
Stock Price
497.40
Market Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 7.47B, an increase of 19,956.28%. That is a compound annual growth rate of 30.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 7.47B | -9.75% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 58.19B |
| Getinge AB | 53.45B |
| Elekta AB | 20.02B |
| Nolato AB | 13.19B |
| Vitrolife AB | 12.97B |
| Xvivo Perfusion AB | 8.41B |
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |